Thus, although we have not shown that the variant c-Myb proteins are expressed in the leukemias, the sensitivity of the RNA-based assay makes it more useful than analyzing proteins and its usefulness as a biomarker is not diminished even if the proteins are not expressed. Here, MYB is linked to leukemia.